Shouyao Holdings (Beijing) Co., LTD. (SHA:688197)

China flag China · Delayed Price · Currency is CNY
39.46
-2.49 (-5.94%)
At close: Apr 21, 2026
Market Cap5.87B +30.6%
Revenue (ttm)34.67M +483.4%
Net Income-93.17M
EPS-0.63
Shares Out148.72M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,147,879
Average Volume1,922,128
Open41.73
Previous Close41.95
Day's Range39.40 - 41.95
52-Week Range29.26 - 56.86
Beta0.82
RSI49.22
Earnings DateApr 18, 2026

About SHA:688197

Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of innovative drugs in China. The company offers drugs for various indications, including non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, breast cancer, ovarian cancer, thyroid cancer, leukemia, and diabetes. The company was founded in 2016 and is headquartered in Beijing, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Employees 172
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688197
Full Company Profile

Financial Performance

In 2025, SHA:688197's revenue was 8.67 million, an increase of 119.88% compared to the previous year's 3.94 million. Losses were -128.83 million, -39.21% less than in 2024.

Financial Statements